207 related articles for article (PubMed ID: 11650030)
1. Implications of the federal drug investigation and approval processes for the development and availability of AIDS treatments and vaccines.
Mathers PR
AIDS Public Policy J; 1987; 2(2):50-3. PubMed ID: 11650030
[No Abstract] [Full Text] [Related]
2. AIDS treatment drugs: clinical trials and compassionate use.
Levine RJ
AIDS Public Policy J; 1987; 2(2):6-8. PubMed ID: 11650031
[No Abstract] [Full Text] [Related]
3. FDA treatment use regulations: a compassionate response.
Weitzman SA; Marcy T
AIDS Public Policy J; 1987; 2(2):22-32. PubMed ID: 11650028
[No Abstract] [Full Text] [Related]
4. Private rights to adulterated/misbranded articles.
McMonagle L
AIDS Public Policy J; 1987; 2(2):33-49. PubMed ID: 11650029
[No Abstract] [Full Text] [Related]
5. Experimental drugs: more of them, but they're no longer free.
Caplan J
Hastings Cent Rep; 1987 Jun; 17(3):3. PubMed ID: 11644019
[No Abstract] [Full Text] [Related]
6. Shaking up the status quo: how AIDS activists have challenged drug development and approval procedures.
Dunbar MM
Food Drug Cosmet Law J; 1991 Sep; 46(5):673-706. PubMed ID: 11651380
[No Abstract] [Full Text] [Related]
7. Getting new drugs to people with AIDS: a public policy response to Lansdale.
Cohen MN
Hastings Constit Law Q; 1991; 18(3):471-85. PubMed ID: 11651493
[No Abstract] [Full Text] [Related]
8. The FDA's response to AIDS: paradigm shift in new drug policy?
Podraza R
Food Drug Law J; 1993; 48(3):351-75. PubMed ID: 11653267
[No Abstract] [Full Text] [Related]
9. F.D.A. gives quick approval to two drugs to treat AIDS.
Kolata G
N Y Times Web; 1989 Jun; ():A1, B4. PubMed ID: 11646728
[No Abstract] [Full Text] [Related]
10. The F.D.A.'s callous response to AIDS.
Kramer L
N Y Times Web; 1987 Mar; ():A19. PubMed ID: 11646190
[No Abstract] [Full Text] [Related]
11. Vaccination for AIDS: legal and ethical challenges from the test tube, to the human subject, through to the marketplace.
Gostin L
AIDS Public Policy J; 1987; 2(2):9-16. PubMed ID: 11650032
[No Abstract] [Full Text] [Related]
12. U.S. permits AIDS patients to use unproved drug.
Kolata G
N Y Times Web; 1989 Jan; ():A1, B6. PubMed ID: 11646713
[No Abstract] [Full Text] [Related]
13. The right of privacy in choosing medical treatment: should terminally ill persons have access to drugs not yet approved by the Food and Drug Administration?
Power SH
John Marshall Law Rev; 1987; 20(4):693-714. PubMed ID: 11650094
[No Abstract] [Full Text] [Related]
14. Resolution: RU 486.
American Association for the Advancement of Science
Science; 1991 Apr; 252(5005):587. PubMed ID: 11642875
[No Abstract] [Full Text] [Related]
15. F.D.A., in big shift, will permit use of experimental AIDS drug.
Hilts PJ
N Y Times Web; 1989 Sep; ():A1, A16. PubMed ID: 11646735
[No Abstract] [Full Text] [Related]
16. Twice wrong on AIDS.
Gieringer D
N Y Times Web; 1987 Jan; ():A21. PubMed ID: 11646161
[No Abstract] [Full Text] [Related]
17. AIDS and drug pricing: in search of a policy.
Salbu SR
Wash Univ Law Q; 1993; 71(3):691-734. PubMed ID: 11652750
[No Abstract] [Full Text] [Related]
18. Regulatory concerns regarding AIDS vaccine development.
Sawyer LA; Katzenstein DA; Quinnan GV
AIDS Public Policy J; 1988; 3(3):36-45. PubMed ID: 11650100
[No Abstract] [Full Text] [Related]
19. Faith (healing), hope and charity at the FDA: the politics of AIDS drug trials.
Annas GJ
Villanova Law Rev; 1989 Sep; 34(5):771-97. PubMed ID: 11651162
[No Abstract] [Full Text] [Related]
20. Women and HIV/AIDS research: the barriers to equity.
Levine C
IRB; 1991; 13(1-2):18-22. PubMed ID: 11659324
[No Abstract] [Full Text] [Related]
[Next] [New Search]
